Rastogi et al. evaluated fine-tuned transfer-learning architectures for brain tumor classification using MRI, reporting the best performance with Xception on a Kaggle-sourced dataset of tumor and non-tumor images [1]. The computational aim is clear; however, several design choices could inflate apparent performance and complicate clinical translation.
First, subject-level separation is essential to avoid inadvertent information leakage. Public MRI collections on Kaggle commonly aggregate multiple slices per subject and heterogeneous acquisitions. If random image-level splits are used, near-duplicate slices from the same person can land in both training and testing, allowing models to memorize anatomy or scanner-specific textures rather than learn generalizable pathology signatures. Reporting a patient-level split, with sequence-aware grouping when possible, or a site-withheld validation would quantify optimism arising from slice-level peeking and align the model to a plausible clinical use case [2,3].
Second, preprocessing, augmentation, and feature selection must be nested within resampling to avoid pipeline leakage. Imputation, normalization, augmentation decisions, and hyperparameter tuning (including fine-tuning schedules) should strictly be fit on training folds and then applied unchanged to held-out data. Estimating these steps on the full dataset, or tuning and evaluating within the same loop without nesting, allows outcome-related structure to bleed into validation, inflating discrimination [4]. Clear documentation of fold-wise preprocessing with fixed random seeds supports reproducibility and external appraisal [2,3].
Third, beyond accuracy on a single split, transportability under drift warrants a stricter check. MRI protocols, scanners, and patient mix evolve over time; repeated nested cross-validation plus an external or temporally separated hold-out provide a tighter stress test than one random division. Furthermore, classification probabilities should be calibrated and their uncertainty reported so that predicted risks map to observed outcomes across thresholds. Finally, decision-curve analysis connects calibrated output to action thresholds in practice (e.g., triage to advanced imaging), quantifying net benefit versus default strategies [5].
At the bedside and in multidisciplinary tumor boards, the distinction between anticipating disease and recognizing dataset-specific textures is decisive. If slice-level duplicates or acquisition-specific artifacts slip into both training and testing, performance will look high but the tool may fail on a new scanner or protocol. Building the pipeline around patient-level splits, leakage-safe nested tuning, and temporally or externally separated validation, paired with calibration and decision-analytic reporting, allows the reported accuracy to be a fair reflection of what clinicians can expect and links statistical performance to day-to-day safety.
Conflicts of Interest
The author declares no conflicts of interest.
References
- Rastogi, D.; Johri, P.; Donelli, M.; Kumar, L.; Bindewari, S.; Raghav, A.; Khatri, S.K. Brain Tumor Detection and Prediction in MRI Images Utilizing a Fine-Tuned Transfer Learning Model Integrated Within Deep Learning Frameworks. Life 2025, 15, 327. [Google Scholar] [CrossRef] [PubMed]
- Collins, G.S.; Moons, K.G.M.; Dhiman, P. TRIPOD+AI: Updated reporting guidance for clinical prediction models using regression or machine-learning methods. BMJ 2024, 385, e078378. [Google Scholar] [CrossRef] [PubMed]
- Moons, K.G.M.; Damen, J.A.A.; Kaul, T.; Hooft, L.; Navarro, C.A.; Dhiman, P.; Beam, A.L.; Calster, B.V.; Celi, L.A.; Denaxas, S.; et al. PROBAST+AI: Updated tool to assess risk of bias and applicability of prediction models using regression or AI. BMJ 2025, 388, e082505. [Google Scholar] [CrossRef] [PubMed]
- Kaufman, S.; Rosset, S.; Perlich, C.; Stitelman, O. Leakage in Data Mining: Formulation, Detection, and Avoidance. ACM Trans. Knowl. Discov. Data 2012, 6, 15. [Google Scholar] [CrossRef]
- Vickers, A.J.; Van Calster, B.; Steyerberg, E.W. A simple guide to decision-curve analysis. Diagn. Progn. Res. 2019, 3, 18. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.